179 related articles for article (PubMed ID: 36038839)
1. Serum anti-SPP1 autoantibody as a potential novel biomarker in detection of esophageal squamous cell carcinoma.
Wang C; Sun G; Wang H; Dai L; Zhang J; Du R
BMC Cancer; 2022 Aug; 22(1):932. PubMed ID: 36038839
[TBL] [Abstract][Full Text] [Related]
2. Anti-CXCL8 Autoantibody: A Potential Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma.
Chen H; Sun G; Han Z; Wang H; Li J; Ye H; Song C; Zhang J; Wang P
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295640
[No Abstract] [Full Text] [Related]
3. Identification of glutathione S-transferase omega 1 (GSTO1) protein as a novel tumor-associated antigen and its autoantibody in human esophageal squamous cell carcinoma.
Li Y; Zhang Q; Peng B; Shao Q; Qian W; Zhang JY
Tumour Biol; 2014 Nov; 35(11):10871-7. PubMed ID: 25085586
[TBL] [Abstract][Full Text] [Related]
4. ZPR1 is an immunodiagnostic biomarker and promotes tumor progression in esophageal squamous cell carcinoma.
Sun G; Ye H; Liu H; Li T; Li J; Zhang X; Cheng Y; Wang K; Shi J; Dai L; Wang P
Cancer Sci; 2024 Jan; 115(1):70-82. PubMed ID: 37964506
[TBL] [Abstract][Full Text] [Related]
5. Serum anti-TOPO48 autoantibody as a biomarker for early diagnosis and prognosis in patients with esophageal squamous cell carcinoma.
Zhang JB; Cao M; Chen J; Ye SR; Xie K; He X; Ma XL; Zhang J; Yie SM
Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):276-284. PubMed ID: 29170084
[TBL] [Abstract][Full Text] [Related]
6. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
[TBL] [Abstract][Full Text] [Related]
7. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.
Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL
J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma.
Zhou JH; Zhang B; Kernstine KH; Zhong L
World J Gastroenterol; 2011 Mar; 17(10):1373-8. PubMed ID: 21455340
[TBL] [Abstract][Full Text] [Related]
9. Development of a panel of autoantibody against NSG1 with CEA, CYFRA21-1, and SCC-Ag for the diagnosis of esophageal squamous cell carcinoma.
Zheng Q; Zhang L; Tu M; Yin X; Cai L; Zhang S; Yu L; Pan X; Huang Y
Clin Chim Acta; 2021 Sep; 520():126-132. PubMed ID: 34119530
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Serum Biomarker Panel for the Detection of Esophageal Squamous Cell Carcinoma through RNA Transcriptome Sequencing.
Xing S; Zheng X; Wei LQ; Song SJ; Liu D; Xue N; Liu XM; Wu MT; Zhong Q; Huang CM; Zeng MS; Liu WL
J Cancer; 2017; 8(12):2346-2355. PubMed ID: 28819439
[TBL] [Abstract][Full Text] [Related]
11. Combined detection of serum Dickkopf-1 and its autoantibodies to diagnose esophageal squamous cell carcinoma.
Peng YH; Xu YW; Guo H; Huang LS; Tan HZ; Hong CQ; Li SS; Xu LY; Li EM
Cancer Med; 2016 Jul; 5(7):1388-96. PubMed ID: 26988995
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies as potential biomarkers for the early detection of esophageal squamous cell carcinoma.
Xu YW; Peng YH; Chen B; Wu ZY; Wu JY; Shen JH; Zheng CP; Wang SH; Guo HP; Li EM; Xu LY
Am J Gastroenterol; 2014 Jan; 109(1):36-45. PubMed ID: 24296751
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of anti-MAGEA family protein autoantibodies in esophageal squamous cell carcinoma.
Sun G; Chen H; Xia J; Li T; Ye H; Li J; Zhang X; Cheng Y; Wang K; Shi J; Wang P
Int Immunopharmacol; 2023 Dec; 125(Pt A):111041. PubMed ID: 37866309
[TBL] [Abstract][Full Text] [Related]
14. Identification and Evaluation of Autoantibody to a Novel Tumor-Associated Antigen GNA11 as a Biomarker in Esophageal Squamous Cell Carcinoma.
Wang H; Yang X; Sun G; Yang Q; Cui C; Wang X; Ye H; Dai L; Shi J; Zhang J; Wang P
Front Oncol; 2021; 11():661043. PubMed ID: 34568004
[TBL] [Abstract][Full Text] [Related]
15. Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma.
Luo Y; Hong CQ; Huang BL; Ding TY; Chu LY; Zhang B; Qu QQ; Li XH; Liu CT; Peng YH; Guo HP; Xu YW
Ann Med; 2022 Dec; 54(1):2153-2166. PubMed ID: 35930383
[TBL] [Abstract][Full Text] [Related]
16. Discovery and Validation of a Serologic Autoantibody Panel for Early Diagnosis of Esophageal Squamous Cell Carcinoma.
Pan J; Zheng QZ; Li Y; Yu LL; Wu QW; Zheng JY; Pan XJ; Xie BS; Wu YA; Qian J; Zhu H; Huang Y
Cancer Epidemiol Biomarkers Prev; 2019 Sep; 28(9):1454-1460. PubMed ID: 31239266
[TBL] [Abstract][Full Text] [Related]
17. Peroxiredoxin 1 is a tumor-associated antigen in esophageal squamous cell carcinoma.
Ren P; Ye H; Dai L; Liu M; Liu X; Chai Y; Shao Q; Li Y; Lei N; Peng B; Yao W; Zhang J
Oncol Rep; 2013 Nov; 30(5):2297-303. PubMed ID: 24009050
[TBL] [Abstract][Full Text] [Related]
18. Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival.
Xing S; Zheng X; Zeng T; Zeng MS; Zhong Q; Cao YS; Pan KL; Wei C; Hou F; Liu WL
World J Gastroenterol; 2017 Nov; 23(43):7693-7704. PubMed ID: 29209110
[TBL] [Abstract][Full Text] [Related]
19. KPNA2 is a promising biomarker candidate for esophageal squamous cell carcinoma and correlates with cell proliferation.
Ma S; Zhao X
Oncol Rep; 2014 Oct; 32(4):1631-7. PubMed ID: 25109899
[TBL] [Abstract][Full Text] [Related]
20. A panel of autoantibodies against multiple tumor-associated antigens in the immunodiagnosis of esophageal squamous cell cancer.
Zhang HF; Qin JJ; Ren PF; Shi JX; Xia JF; Ye H; Wang P; Song CH; Wang KJ; Zhang JY
Cancer Immunol Immunother; 2016 Oct; 65(10):1233-42. PubMed ID: 27553002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
